All Infection Prevention & Control articles – Page 20
-
NewsImaging technique is step towards needed treatments for hantaviruses in new molecular ma
Researchers have produced a detailed blueprint, the highest resolution yet, for a protein complex the Andes virus uses to infect host cells. The new detailed structural information enabled the researchers to produce a vaccine candidate that caused mice to produce neutralizing antibodies against the Andes virus.
-
NewsAcoziborole Winthrop receives European Medicines Agency positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness
The European Medicines Agency has granted a positive opinion to Acoziborole Winthrop (acoziborole) as a single-dose oral treatment for both early- and advanced-stage gambiense sleeping sickness in adults as well as in adolescents 12 years and older weighing at least 40 kilograms.
-
NewsScientists identify key protein that stops malaria parasite growth
An international team of scientists have identified a unique protein essential for the malaria parasite’s survival and transmission. Aurora-related kinase 1 (ARK1) acts as a ‘traffic controller’ during the parasite’s unusual cell division and growth process.
-
NewsDiffering immune responses in infants may explain increased severity of RSV over SARS-CoV-2
Reseachers report that the two respiratory viruses trigger different immune responses. Those differences might explain why these two diseases have different clinical outcomes and require different treatment strategies.
-
NewsEmerging class of antibiotics to tackle global tuberculosis crisis
Researchers investigated how three naturally occurring antibiotic compounds – ecumicin, ilamycin and cyclomarin – act on a vital protein degradation machine inside Mycobacterium tuberculosis, the bacterium that causes TB.
-
NewsHPV vaccination provides “sustained protection” against cervical cancer
Human papillomavirus (HPV) vaccination is associated with a significantly reduced risk of invasive cervical cancer, with no indication of waning protection up to 18 years after vaccination, finds a study.
-
NewsVaccine uptake: Why conspiracy theories can be so irresistible
New research has found that understanding how someone processes information can be a strong predictor of whether they are drawn to conspiracy beliefs that can influence vaccine uptake, trust in institutions and responses to emergencies.
-
NewsMeningococcal B vaccination does not reduce gonorrhoea, trial results show
Contrary to existing evidence from observational studies, the meningococcal B vaccine (4CMenB) has no effect on preventing the acquisition of gonorrhoea, according to the results of the world’s largest randomised control trial (RCT) into possible efficacy.
-
NewsUrinary tract infections can trigger delirium and worsen dementia
Urinary tract infections can pose serious risks for older adults, particularly those with Alzheimer’s disease and other forms of dementia. In older patients, a common UTI can trigger delirium, a medical emergency marked by sudden confusion and altered awareness.
-
NewsNew strategies aim at HIV’s last strongholds
A new study has overcome a long-standing challenge—how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease difficult to cure.
-
NewsA comparison of the efficacy of non-chemical versus chemical cleansers against Candida species on removable dental prostheses
A new review aims to systematically compare the efficacy of chemical and non-chemical denture cleansers in reducing Candida spp. on removable dental prostheses.
-
NewsNew study finds sex and menopause-based differences in presentation of early Lyme disease
In a new study, researchers found that male and female patients with early Lyme disease present with different signs of the disease in the symptoms they report, their physical exams and their laboratory test results.
-
NewsScientists find that silencing bacteria can worsen heart infections
By studying a bacterium responsible for a severe heart infection, the scientists show that disrupting bacterial communication can be associated with adverse clinical outcomes. These findings open the door to more targeted therapeutic strategies against this type of infection.
-
NewsYou don’t need to be very altruistic to stop an epidemic
Researchers have used a mathematical model of epidemic behaviour to find that even people who are only barely altruistic - valuing their own life as equivalent to the lives of around 100,000 others – would still see it as rational to drastically reduce their social contacts when infected.
-
NewsThe hidden infections that refuse to go away: how household practices can stop deadly diseases
A 13-year study reveals why a deadly parasitic infection targeted for elimination in China persisted in some areas even after decades of control. The research investigated some of the last pockets of schistosomiasis in the country, finding that farming practices and unsafe sanitation contributed to disease spread.
-
NewsFirst evidence of fungal pathogen becoming more deadly when co-infected with tuberculosis
Co-infection of Mycobacterium tuberculosis, together with Cryptococcus neoformans, is a grave public health concern, increasing the risk of death significantly. Researchers have found that in the presence of Mycobacteria, the fungus changed its cell density, cell diversity, and capsule size.
-
News Huayunuo approval positions China at forefront of viral hepatitis innovation, says GlobalData
Huahui Health has recently secured conditional approval from China for Huayunuo (Libevitug Injection), marking it as the first domestically developed monoclonal antibody (mAb) drug for chronic hepatitis D virus (HDV) infection in adults with or without compensated cirrhosis.
-
NewsElevated E. coli, staph still detected in Potomac river 4 weeks after sewage spill
Nearly a month after a wastewater pipe broke and spewed hundreds of millions of gallons of raw sewage into the Potomac River just north of Washington, D.C., the latest water testing results continue to show high levels of E. coli and S. aureus, including antibiotic-resistant MRSA.
-
NewsHoly Grail: One vaccine may provide broad protection against many respiratory infections and allergens
In a new study in mice, researchers have developed a universal vaccine formula that protects against a wide range of respiratory viruses, bacteria and even allergens.
-
NewsNew findings on infection with the Epstein-Barr virus
Researchers have identified genetic and non-genetic factors that help the body fight the Epstein-Barr virus. Using a new technique, they were able to estimate the amount of EBV in the blood and find correlations in large health data sets – for example, an increased viral load in people with HIV infections, but also in smokers.